CAS: 1228763-95-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Monalizumab REF: TM-T76691CAS: 1228763-95-8 | 95% - SDS-PAGE:95% SEC-HPLC:95% | 407.00 €~3,461.00 € | Thu 24 Oct 24 |
 | Monalizumab REF: 3D-CLA1399CAS: 1228763-95-8 | - - - | To inquire | Tue 05 Nov 24 |
Monalizumab
CAS:1228763-95-8
Monalizumab, a humanized antibody, enhances NK cell function by inhibiting NKG2A; used in HNSCC studies.
Purity:
95% - SDS-PAGE:95% SEC-HPLC:95%
Color and Shape:
Solid
Ref: TM-T76691
| 1mg | 407.00 € | ||
| 5mg | 916.00 € | ||
| 10mg | 1,281.00 € | ||
| 25mg | 1,838.00 € | ||
| 50mg | 2,588.00 € | ||
| 100mg | 3,461.00 € |
Estimated delivery in United States, on Thursday 24 Oct 2024
Ref: 3D-CLA1399
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 5 Nov 2024
